Endometrial/endometrioid stromal tumors with extensive whorling and CTNNB1 translocation: A report of 3 cases Journal Article


Authors: Boyraz, B.; da Cruz Paula, A.; Deveraux, K. A.; Tran, I.; da Silva, E. M.; Young, R. H.; Snuderl, M.; Weigelt, B.; Oliva, E.
Article Title: Endometrial/endometrioid stromal tumors with extensive whorling and CTNNB1 translocation: A report of 3 cases
Abstract: Endometrial/endometrioid stromal tumors are rare and morphologically heterogenous, and their diagnosis may be challenging. We identified 3 endometrial/endometrioid stromal tumors with identical and previously undescribed histologic features and herein report their morphologic, immunohistochemical, and molecular profiles. Patients were 53, 62, and 79 years. Tumors were well-circumscribed, tan-yellow solid masses measuring 10.0, 11.0, and 18.7 cm, and were intramyometrial (n=2) or in the broad ligament (n=1). All showed small, tight whorls of epithelioid to slightly spindled tumor cells with minimal cytoplasm and negligible mitoses, multifocally associated with hyalinization and myxoid change set in a loose fibroblastic background with small, delicate vessels. This morphology was seen throughout in 1 tumor and in ∼20% and 70% of the 2 others with the remaining areas showing sex cord-like differentiation. Tumor cells expressed CD10 (3/3, 1 focal), calretinin (3/3 diffuse), WT1 (3/3 diffuse), estrogen receptor (1/1, diffuse). RNA-sequencing was successful in 1 tumor and revealed a GREB1-CTNNB1 in-frame fusion. All 3 tumors harbored a CTNNB1 translocation by fluorescence in situ hybridization correlating with nuclear β-catenin expression. Whole-genome DNA methylation analysis classified all 3 tumors within the low-grade endometrial stromal sarcoma reference class with flat copy number profiles. One patient (79-y-old) died of unrelated causes 2 months after surgery and the other 2 were alive without disease after 13 and 75 months. We have described a rare subset of endometrial/endometrioid stromal tumors with extensive whorling and a CTNNB1 translocation, expanding the morphologic and molecular spectrum of these neoplasms. © 2023 Lippincott Williams and Wilkins. All rights reserved.
Keywords: genetics; case report; endometrial neoplasms; mitosis; metabolism; in situ hybridization, fluorescence; pathology; tumor marker; fluorescence in situ hybridization; beta catenin; endometrium tumor; ctnnb1 protein, human; endometrial stromal tumor; beta-catenin; endometrium sarcoma; sarcoma, endometrial stromal; endometrial stromal tumors; ctnnb1; humans; human; female; biomarkers, tumor
Journal Title: American Journal of Surgical Pathology
Volume: 47
Issue: 11
ISSN: 0147-5185
Publisher: Lippincott Williams & Wilkins  
Date Published: 2023-11-01
Start Page: 1285
End Page: 1290
Language: English
DOI: 10.1097/pas.0000000000002094
PUBMED: 37584555
PROVIDER: scopus
PMCID: PMC11180543
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Britta Weigelt
    632 Weigelt